0 Recommendations
Has anyone used the oral drug Etoposide for treatment? Can you tell me your expenses like side effects what dosages, how often etc…. This is my second diagnoses.
Already a member? Sign in
Welcome to Inspire!
What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.
Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.
How - Joining Inspire is completely free and usually takes less than a minute. Join now!
Etoposide
Explore topics in this discussion:
Epithelial ovarian carcinoma (EOC) Cancer Avastin Paclitaxel
3 replies
- Oldest first
- Newest first
- By Adele9166
- Posted June 30, 2009 at 10:34 pm
- Report post
Thank You for sharing your experience. Pot! Yes, Im considering it.
- By shoppingkharma
- Posted June 14, 2009 at 11:25 am
- Report post
I was on Etoposide for about 4 months (Aug. 08 - Dec. 08). It was a good drug and mine was used with Avastin. The side effects that I had were not so pleasant but I did smoke pot and that worked just fine getting rid of those side effects.
1) feeling of having glass in my stomach (painful)
2) metal taste in my mouth, nausea
Hope this helps and make sure that you drink plenty of water because it will make you not feel like drinking and the pot helped me to drink more.
- By gpawelski
- Posted June 13, 2009 at 2:11 pm
- Report post
According to researchers at Fox Chase Cancer Center, despite improvements in median and overall survival using a combination of platinum and paclitaxel, long-term survival rates for patients with advanced epithelial ovarian carcinoma (EOC) remain disappointing, and the development of more effective primay therapy remains a priority.
In particular, several nonplatinum agents have demonstrated activity in clinical trials among patients with recurrent platinum-resistant EOC. Among these are gemcitabine, topotecan, liposomal doxorubicin, and prolonged oral etoposide.
Clinical models have indicated a biologic basis for combinations of these agents with platinum, which has been attributed to inhibition of pathways involved in DNA repair.
Add to the discussion